Dr Suri Lab Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 157.78%
- Profit Growth 312.15%
- Ebitda 5079.73%
- Net Worth 91.99%
- Total Assets 56.26%
About Dr Suri Lab
Dr Suri Lab Private Limited (DSLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 March 2001 and has a history of 23 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Jagpal Suri, Avinash Suri, and Pradeep Suri serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85195DL2001PTC109865
-
Company No.
109865
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Mar 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dr Suri Lab?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Suri
|
Managing Director | 10-Sep-2001 | Current |
|
Jagpal Suri
|
Managing Director | 02-Mar-2001 | Current |
|
Avinash Suri
|
Managing Director | 02-Mar-2001 | Current |
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Dr Suri Lab.
Dr Suri Lab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 157.78% increase. The company also saw a substantial improvement in profitability, with a 312.15% increase in profit. The company's net worth Soared by an impressive increase of 91.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Suri Lab?
Unlock access to Dr Suri Lab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Jap Healthcare Private LimitedJagpal Suri, Avinash Suri and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Suri Lab?
Dr Suri Lab has a workforce of 22 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Suri Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Suri Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.